ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · IEX Real-Time Price · USD
0.750
-0.019 (-2.47%)
At close: Mar 28, 2024, 4:00 PM
0.765
+0.015 (2.00%)
After-hours: Mar 28, 2024, 7:59 PM EDT

ZyVersa Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Net Income
-106.25-24.06-8.08-12.68
Depreciation & Amortization
0.010.010.010.01
Share-Based Compensation
1.193.524.143.68
Other Operating Activities
88.379.02-1.143.89
Operating Cash Flow
-8.72-1.49-5.08-5.11
Share Issuance / Repurchase
15.69003
Debt Issued / Paid
005.231.54
Other Financing Activities
-9.731.87-0.02
Financing Cash Flow
5.961.875.234.56
Net Cash Flow
-2.760.370.15-0.55
Free Cash Flow
-8.72-1.49-5.08-5.11
Free Cash Flow Per Share
-8.94-0.06-7.35-7.57
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).